A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy Infants
Interventions
BIOLOGICAL

Eutravac

Trial Locations (7)

301-723

Daejeon St. Mary's Hospital, Daejeon

442-723

The Catholic University of Korea ST. Vincent's Hospital, Suwon

400-711

Inha University Hospital, Incheon

690-767

Jeju National University Hospital, Jeju City

130-872

Kyung Hee University Hospital, Seoul

135-913

Cha Hospital, Seoul

139-709

Korea Cancer Center Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT01896739 - A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants | Biotech Hunter | Biotech Hunter